Watch List: Neurocrine Biosciences (NASDAQ:NBIX), Karyopharm Therapeutics Inc (NASDAQ:KPTI), Catalyst Pharmaceutical (NASDAQ:CPRX), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), The Medicines Company (NASDAQ:MDCO)

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) announced that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Jefferies 2014 Global Healthcare Conference in New York City. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock performance was 0.22% in last session and finished the day at $13.94. Traded volume was million shares in the last session and the average volume of the stock remained 815.19K … Continue reading Watch List: Neurocrine Biosciences (NASDAQ:NBIX), Karyopharm Therapeutics Inc (NASDAQ:KPTI), Catalyst Pharmaceutical (NASDAQ:CPRX), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), The Medicines Company (NASDAQ:MDCO)

Colin Pettis06/0406/04

Drugs Generic: Neurocrine Biosciences (NASDAQ:NBIX), The Medicines Company (NASDAQ:MDCO), Avanir Pharmaceuticals (NASDAQ:AVNR), Horizon Pharma (NASDAQ:HZNP)

Investors eyeing a purchase of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock, but tentative about paying the going market price of $14.27/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $11 strike, which has a bid at the time of this writing of $1.65. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock performance … Continue reading Drugs Generic: Neurocrine Biosciences (NASDAQ:NBIX), The Medicines Company (NASDAQ:MDCO), Avanir Pharmaceuticals (NASDAQ:AVNR), Horizon Pharma (NASDAQ:HZNP)

Richard Atkins04/0904/09